Open access · CC-BY
via OpenAlex
Alzheimer’s Disease Seen through the Eye: Ocular Alterations and Neurodegeneration
Daniel Romaus‐Sanjurjo, Uxía Regueiro, Maite López‐López, Laura Vázquez‐Vázquez, Alberto Ouro, Isabel Lema, Tomás Sobrino
International Journal of Molecular Sciences · 2022 · ▲ 56 citations
Abstract
diagnosis. Therefore, it is urgent to find biomarkers to allow for early diagnosis of the disease. There is increasing scientific evidence highlighting the similarities between the eye and other structures of the CNS, suggesting that knowledge acquired in eye research could be useful for research and diagnosis of AD. For example, the retina and optic nerve are considered part of the central nervous system, and their damage can result in retrograde and anterograde axon degeneration, as well as abnormal protein aggregation. In the anterior eye segment, the aqueous humor and tear film may be comparable to the cerebrospinal fluid. Both fluids are enriched with molecules that can be potential neurodegenerative biomarkers. Indeed, the pathophysiology of AD, characterized by cerebral deposits of amyloid-beta (Aβ) and tau protein, is also present in the eyes of AD patients, besides numerous structural and functional changes observed in the structure of the eyes. Therefore, all this evidence suggests that ocular changes have the potential to be used as either predictive values for AD assessment or as diagnostic tools.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms23052486
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
Romaus‐Sanjurjo, D., Regueiro, U., López‐López, M., Vázquez‐Vázquez, L., Ouro, A., Lema, I., & Sobrino, T. (2022). Alzheimer’s Disease Seen through the Eye: Ocular Alterations and Neurodegeneration. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms23052486
Vancouver
Romaus‐Sanjurjo D, Regueiro U, López‐López M, Vázquez‐Vázquez L, Ouro A, Lema I, et al. Alzheimer’s Disease Seen through the Eye: Ocular Alterations and Neurodegeneration. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms23052486.
BibTeX
@article{daniel2022Alzhei,
title = {Alzheimer’s Disease Seen through the Eye: Ocular Alterations and Neurodegeneration},
author = {Daniel Romaus‐Sanjurjo and Uxía Regueiro and Maite López‐López and Laura Vázquez‐Vázquez and Alberto Ouro and Isabel Lema and Tomás Sobrino},
journal = {International Journal of Molecular Sciences},
year = {2022},
doi = {10.3390/ijms23052486},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2022
Open access · CC-BY
Amyloid Beta in Aging and Alzheimer’s Disease
CNS & neurological disorders drug targets 2026
Citation only
Linking Neurodegeneration and Age-related Macular Degeneration: Unified Pathways and Intervention Strategies.
Frontiers in Psychology 2014
Open access · CC-BY
Visual cortex in aging and Alzheimer's disease: changes in visual field maps and population receptive fields
BENTHAM SCIENCE PUBLISHERS eBooks 2017
Citation only
Retinal Neurodegeneration in Alzheimer’s Disease
Cells 2020
Open access · CC-BY
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Translational Vision Science & Technology 2020
Open access · CC-BY